Seeking Alpha

Alexion Pharmaceuticals (ALXN +2.8%) makes a new all-time high after receiving an upgrade to Buy...

Alexion Pharmaceuticals (ALXN +2.8%) makes a new all-time high after receiving an upgrade to Buy from UBS. The firm touts the "defensive growth" offered by Alexion's business model, the potential of its Soliris drug in treating multiple diseases, and improving visibility surrounding the rest of Alexion's pipeline.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|